Explore more about: SPECT

December 3, 2020
News
NIBIB-funded researchers used dual PET and MRI technology to detect increased bone remodeling in the injured knees of patients likely to get osteoarthritis. This increased bone activity was often seen next to areas of early cartilage tissue degradation, suggesting an important link between degenerative changes in neighboring tissues in the disease.
December 9, 2020
News

Medical scientists have developed a novel imaging agent that could be used to identify most bacterial infections. Read more at AuntMinnie.com

December 3, 2020
News
Researchers at NIBIB have developed a new radiotracer to diagnose prostate cancer and conducted a successful Phase I clinical trial. Prostate cancer is the fifth leading cause of death worldwide and is especially difficult to diagnose. While prostate cancer is relatively easy to treat in its early stages, it is prone to metastasis and can quickly become deadly. In order to plan how aggressively they should treat the cancer, it is important for doctors to know how far the cancer has progressed. NIBIB researchers have attempted to solve this problem by developing a radiotracer that could identify prostate cancer at all stages.